Abstract
Juvenile dermatomyositis is an autoimmune disease
seen in children, which causes typical skin changes and
muscle complaints. Invasive diagnostic procedures are
often avoided in children and therefore the patient may
not meet the criteria formulated by Bohan and Peter.
Frequently additional investigations such as MRI, capillaroscopy
and autoantibody screening are needed to reach
a diagnosis. The most common treatment are prednisolone
and methotrexate. The risk of disease-related complications
is reduced if treatment is started in an early
stage of the disease. We describe a patient with a typical
clinical picture of juvenile dermatomyositis, who responded
well to prednisolone and methotrexate.
seen in children, which causes typical skin changes and
muscle complaints. Invasive diagnostic procedures are
often avoided in children and therefore the patient may
not meet the criteria formulated by Bohan and Peter.
Frequently additional investigations such as MRI, capillaroscopy
and autoantibody screening are needed to reach
a diagnosis. The most common treatment are prednisolone
and methotrexate. The risk of disease-related complications
is reduced if treatment is started in an early
stage of the disease. We describe a patient with a typical
clinical picture of juvenile dermatomyositis, who responded
well to prednisolone and methotrexate.
Original language | Dutch |
---|---|
Pages (from-to) | 534-537 |
Number of pages | 4 |
Journal | Nederlands Tijdschrift voor Dermatologie en Venereologie |
Volume | 27 |
Issue number | 10 |
Publication status | Published - Oct 2017 |